DeepMed Research

Laboratorios Sophia, S.A. de C.V.

🇲🇽Mexico

Country: 🇲🇽Mexico

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Safety and Tolerability of the Preservative-free Ophthalmic Solution PRO-122 Compared With Krytantek Ofteno®

Phase 1

Completed

Conditions: Glaucoma

Interventions: Drug: Krytantek Ofteno®
Drug: PRO-122

First Posted Date: 2019-05-29

Last Posted Date: 2019-12-13

Lead Sponsor: Laboratorios Sophia S.A de C.V.

Target Recruit Count: 24

Registration Number: NCT03966365

Locations: 🇲🇽
Unidad Clínica de Bioequivalencia, S. de R.L. de C.V., Guadalajara, Jalisco, Mexico

Safety and Tolerability of the Ophthalmic Solution PRO-179 Compared With Travatan®

Phase 1

Completed

Conditions: Glaucoma

Interventions: Drug: PRO 179
Drug: Travatan 0.004 % Ophthalmic Solution

First Posted Date: 2019-05-28

Last Posted Date: 2019-12-12

Lead Sponsor: Laboratorios Sophia S.A de C.V.

Target Recruit Count: 24

Registration Number: NCT03965052

Locations: 🇲🇽
Jose Navarro Partida, Guadalajara, Jalisco, Mexico

Safety and Tolerability of the Ophthalmic Gel PRO-165 Versus Artelac® Nightime Gel

Phase 1

Completed

Conditions: Dry Eye Syndromes

Interventions: Drug: Artelac
Drug: PRO-165

First Posted Date: 2018-10-05

Last Posted Date: 2024-11-06

Lead Sponsor: Laboratorios Sophia S.A de C.V.

Target Recruit Count: 32

Registration Number: NCT03697876

Locations: 🇲🇽
Leslie victoria Aguilar Saldaña, Mexico city, Mexico

Safety and Tolerability of PRO-143 Ophthalmic Solution in Healthy Volunteers.

Phase 1

Withdrawn

Conditions: Conjunctivitis, Bacterial

Interventions: Drug: PRO-143 Ophthalmic Solution

First Posted Date: 2018-10-05

Last Posted Date: 2018-10-10

Lead Sponsor: Laboratorios Sophia S.A de C.V.

Registration Number: NCT03698045

Locations: 🇲🇽
Independent Clinical Research Center, Guadalajara, Jalisco, Mexico

Efficacy of the Ophthalmic Pazufloxacin 0.6% for Bacterial Conjunctivitis, Compared to Gatifloxacin 0.3%.

Phase 3

Terminated

Conditions: Conjunctivitis, Bacterial

Interventions: Drug: Pazufloxacin
Drug: Zymar

First Posted Date: 2018-10-04

Last Posted Date: 2021-08-24

Lead Sponsor: Laboratorios Sophia S.A de C.V.

Target Recruit Count: 46

Registration Number: NCT03696342

Locations: 🇲🇽
Samuel altamirano Vallejo, Guadalajara, Jalisco, Mexico
🇲🇽
Juan Carlos Serna Ojeda (INBIOMEDyC), Aguascalientes, Mexico
🇲🇽
Instituto Nacional de Pediatria, Mexico City, Mexico

and more 3 locations

Clinical Study of the Efficacy of the Ophthalmic Emulsion PRO-145 for Inflammation and Pain After Phacoemulsification

Phase 3

Completed

Conditions: Cataract

Interventions: Drug: Difluprednate 0.05%
Drug: Prednefrin

First Posted Date: 2018-10-03

Last Posted Date: 2019-12-02

Lead Sponsor: Laboratorios Sophia S.A de C.V.

Target Recruit Count: 178

Registration Number: NCT03693989

Locations: 🇲🇽
Novam y Vita, Guadalajara, Jalisco, Mexico
🇲🇽
Vision Cirugia Ambulatoria, Monterrey, Nuevo Leon, Mexico
🇲🇽
Hospital de la luz, Ciudad de Mexico, Mexico

and more 2 locations

Safety and Tolerability of PRO-087 Versus Xyel Ofteno® and Systane Ultra®, on the Ocular Surface of Healthy Subjects

Phase 1

Completed

Conditions: Lubricant Allergy
Dry Eye Syndromes
Tear Disorder

Interventions: Drug: PRO-087
Drug: Xyel Ofteno
Drug: Systane Ultra

First Posted Date: 2018-05-14

Last Posted Date: 2019-07-19

Lead Sponsor: Laboratorios Sophia S.A de C.V.

Target Recruit Count: 30

Registration Number: NCT03524157

Locations: 🇲🇽
Private Ophthalmological Office, Zapopan, Jalisco, Mexico

Efficacy and Safety of PRO-155 on Inflammation of the Conjunctival Surface in Subjects With Grade I-III Pterygium vs Placebo.

Phase 4

Completed

Conditions: Pterygium
Ocular Pain
Ocular Inflammation
Post-surgical Inflammation

Interventions: Other: Placebo
Drug: PRO-155

First Posted Date: 2018-05-11

Last Posted Date: 2019-11-20

Lead Sponsor: Laboratorios Sophia S.A de C.V.

Target Recruit Count: 166

Registration Number: NCT03521791

Locations: 🇲🇽
Consultorio PRivado Miguel Angel Villanueva, Ciudad de México, Mexico
🇲🇽
catarata y glaucoma de occidente S.A de C.V., Guadalajara, Jalisco, Mexico
🇲🇽
Novam y Vita, Guadalajara, Jalisco, Mexico

Safety and Tolerability of the PRO-174 Versus Sophixín Ofteno®, on the Ocular Surface of Healthy Subjects

Phase 1

Completed

Conditions: Conjunctivitis
Conjunctivitis, Bacterial

Interventions: Drug: PRO-174
Drug: Sophixín Ofteno®

First Posted Date: 2018-05-09

Last Posted Date: 2019-10-25

Lead Sponsor: Laboratorios Sophia S.A de C.V.

Target Recruit Count: 30

Registration Number: NCT03519516

Locations: 🇲🇽
Private Medical Offices, Guadalajara, Jalisco, Mexico

Safety and Tolerability of the Ophthalmic Gel PRO-167 Versus Corneregel® on Healthy Subjects.

Phase 1

Completed

Conditions: Dry Eye Syndrome of Unspecified Lacrimal Gland
Dry Eye

Interventions: Drug: PRO-167
Drug: Corneregel

First Posted Date: 2018-05-09

Last Posted Date: 2019-07-19

Lead Sponsor: Laboratorios Sophia S.A de C.V.

Target Recruit Count: 24

Registration Number: NCT03520348

Locations: 🇲🇽
Centro Oftalmológico San Angel, Guadalajara, Jalisco, Mexico

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy